Found: 12
Select item for more details and to access through your institution.
Deep Semi Supervised Generative Learning for Automated Tumor Proportion Scoring on NSCLC Tissue Needle Biopsies.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-35501-5
- By:
- Publication type:
- Article
Concordance among four commercially available, validated programmed cell death ligand-1 assays in urothelial carcinoma.
- Published in:
- Diagnostic Pathology, 2019, v. 14, n. 1, p. N.PAG, doi. 10.1186/s13000-019-0873-6
- By:
- Publication type:
- Article
Consistency of tumor and immune cell programmed cell death ligand-1 expression within and between tumor blocks using the VENTANA SP263 assay.
- Published in:
- Diagnostic Pathology, 2018, v. 13, n. 1, p. N.PAG, doi. 10.1186/s13000-018-0725-9
- By:
- Publication type:
- Article
Formation, Clearance, Deposition, Pathogenicity, and Identification of Biopharmaceutical-related Immune Complexes: Review and Case Studies.
- Published in:
- Toxicologic Pathology, 2014, v. 42, n. 4, p. 725, doi. 10.1177/0192623314526475
- By:
- Publication type:
- Article
Resolution of Skin Fibrosis by Neutralization of the Antifibrinolytic Function of Plasminogen Activator Inhibitor 1.
- Published in:
- Arthritis & Rheumatology, 2016, v. 68, n. 2, p. 473, doi. 10.1002/art.39443
- By:
- Publication type:
- Article
The Safety of EXPAREL (Bupivacaine Liposome Injectable Suspension) Administered by Peripheral Nerve Block in Rabbits and Dogs.
- Published in:
- Journal of Drug Delivery, 2012, p. 1, doi. 10.1155/2012/962101
- By:
- Publication type:
- Article
Safety Evaluation of EXPAREL (DepoFoam Bupivacaine) Administered by Repeated Subcutaneous Injection in Rabbits and Dogs: Species Comparison.
- Published in:
- Journal of Drug Delivery, 2011, p. 1, doi. 10.1155/2011/467429
- By:
- Publication type:
- Article
Analytical Validation and Clinical Utility of an Immunohistochemical Programmed Death Ligand-1 Diagnostic Assay and Combined Tumor and Immune Cell Scoring Algorithm for Durvalumab in Urothelial Carcinoma.
- Published in:
- Archives of Pathology & Laboratory Medicine, 2019, v. 143, n. 6, p. 722, doi. 10.5858/arpa.2017-0555-OA)
- By:
- Publication type:
- Article
Optimal PD-L1–high cutoff for association with overall survival in patients with urothelial cancer treated with durvalumab monotherapy.
- Published in:
- PLoS ONE, 2020, v. 15, n. 4, p. 1, doi. 10.1371/journal.pone.0231936
- By:
- Publication type:
- Article
ASCT2-Targeting Antibody-Drug Conjugate MEDI7247 in Adult Patients with Relapsed/Refractory Hematological Malignancies: A First-in-Human, Phase 1 Study.
- Published in:
- Targeted Oncology, 2024, v. 19, n. 3, p. 321, doi. 10.1007/s11523-024-01054-z
- By:
- Publication type:
- Article
Development of a programmed cell death ligand-1 immunohistochemical assay validated for analysis of non-small cell lung cancer and head and neck squamous cell carcinoma.
- Published in:
- Diagnostic Pathology, 2016, v. 11, p. 1, doi. 10.1186/s13000-016-0545-8
- By:
- Publication type:
- Article
Opposing Roles of Membrane and Soluble Forms of the Receptor for Advanced Glycation End Products in Primary Respiratory Syncytial Virus Infection.
- Published in:
- Journal of Infectious Diseases, 2012, v. 205, n. 8, p. 1311, doi. 10.1093/infdis/jir826
- By:
- Publication type:
- Article